Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancerBenjamin Challoner(Institute of Cancer Research), Marco Gerlinger(Royal Marsden NHS Foundation Trust)bioRxiv (Cold Spring Harbor Laboratory)February 19, 202210.1101/2022.02.16.479224Cited by 1SaveCiteExport RISWatch citationsRelated PapersCEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids|Journal for ImmunoTherapy of Cancer|2019|114Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy|Cancers|2020|7